The Latin America, Middle East and Africa Optical Imaging Market would witness market growth of 19.1% CAGR during the forecast period (2022-2028).
Intraoperative real-time fluorescence imaging has revealed unmatched information during the excision of a broad range of tumor types. An increasing corpus of encouraging evidence supporting the use of optical contrast agents in clinical settings has come from early-phase clinical studies. The standard of care may be greatly improved by fluorescence-guided surgery. Examples of how indocyanine green is used in imaging hepatocellular carcinoma, head and neck cancers, and colorectal, ovarian, and breast malignancies include diagnostic and preoperative planning, in vivo surgical guidance, and ex vivo surgical guiding.
Most of the time, indocyanine green fluorescence imaging has high sensitivity but low specificity. Rapid and sensitive assays for early tumor detection and precise assessment of surgical margins in cancer may be made possible by molecular contrast agents, such as the fluorescent poly(adenosine diphosphate ribose) polymerase inhibitor specific to poly(adenosine diphosphate ribose) polymerase 1. These assays find applications even in settings with limited resources.
1.6 million people—or 4% of the nation's population—are anticipated to be 80 or older by the end of the forecast period. The senior population in Argentina has increased over the last 30 years, going from making up less than 7% of the overall population to around 10%. Also, more than 17% of Buenos Aires City's people are 65 or older. The constantly rising number of older adults in the region due to the high life expectancy will increase the number of patients with various chronic illnesses, which will surge the usage of optical imaging techniques to identify and treat disease and drive market growth in the LAMEA region.
The Brazil market dominated the LAMEA Optical Imaging Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $72.5 Million by 2028. The Argentina market is estimated to grow a CAGR of 19.7% during (2022 - 2028). Additionally, The UAE market would experience a CAGR of 18.8% during (2022 - 2028).
Based on Product, the market is segmented into Imaging Systems, Illuminating Systems, Camera, Software and Lenses & Others. Based on End User, the market is segmented into Hospitals & Clinics, Research Laboratories and Pharmaceutical & Biotechnology Companies. Based on Technique, the market is segmented into Optical Coherence Tomography, Near Infrared Spectroscopy, Hyperspectral Imaging and Photoacoustic Tomography. Based on Application, the market is segmented into Pathological Imaging and Intraoperative Imaging. Based on Therapeutic Area, the market is segmented into Oncology, Ophthalmology, Cardiology, Dermatology, Neurology and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Worldwide Optical Imaging Market is Projected to reach USD 3.1 Billion by 2028, at a CAGR of 13.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Carl Zeiss AG, Leica Microsystems GmbH (Danaher Corporation), Abbott Laboratories, Canon, Inc. (Canon Medical Systems Corporation), PerkinElmer, Inc., Topcon Corporation, Hamamatsu Photonics K.K., Koninklijke Philips N.V., Heidelberg Engineering, Inc. and Visionix Ltd.
By Product
By End User
By Technique
By Application
By Therapeutic Area
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
